These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1451095)

  • 1. Potentiation of mitomycin C cytotoxicity by glutathione depletion in a multi-drug resistant mouse leukemia cell line.
    Xu BH; Singh SV
    Cancer Lett; 1992 Sep; 66(1):49-53. PubMed ID: 1451095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid.
    Singh SV; Xu BH; Maurya AK; Mian AM
    Biochim Biophys Acta; 1992 Nov; 1137(3):257-63. PubMed ID: 1445927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of uptake of mitomycin C and KW-2149 by murine P388 leukemia cells sensitive or resistant to mitomycin C.
    Kobayashi E; Okabe M; Kono M; Arai H; Kasai M; Gomi K; Lee JH; Inaba M; Tsuruo T
    Cancer Chemother Pharmacol; 1993; 32(1):20-4. PubMed ID: 8096440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes.
    Nair S; Singh SV; Samy TS; Krishan A
    Biochem Pharmacol; 1990 Feb; 39(4):723-8. PubMed ID: 2306280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
    Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of P388 leukemia resistant to mitomycin C.
    Rose WC; Huftalen JB; Bradner WT; Schurig JE
    In Vivo; 1987; 1(1):47-52. PubMed ID: 2979764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines.
    Liu QY; Tan BK
    Life Sci; 2000; 67(10):1207-18. PubMed ID: 10954054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
    Singh SV; Xu BH; Gupta V; Emerson EO; Zaren HA; Jani JP
    Cancer Lett; 1995 Aug; 95(1-2):49-56. PubMed ID: 7656243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione S-transferases and glutathione peroxidases in doxorubicin-resistant murine leukemic P388 cells.
    Singh SV; Nair S; Ahmad H; Awasthi YC; Krishan A
    Biochem Pharmacol; 1989 Oct; 38(20):3505-10. PubMed ID: 2818642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
    Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells.
    Parekh H; Chavan S; Chitnis M
    Anticancer Drugs; 1991 Apr; 2(2):159-68. PubMed ID: 1683589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
    Perry RR; Greaves BR; Rasberry U; Barranco SC
    Cancer Res; 1992 Sep; 52(17):4608-12. PubMed ID: 1511428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Scalamogna D; Xia H; O'Toole S; Roy D; Emerson EO; Gupta V; Zaren HA
    Int J Cancer; 1996 Mar; 65(6):852-7. PubMed ID: 8631603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic activity of mitoxantrone and its biological interactions in parental and multidrug resistant subline of P388 murine leukemia cells.
    Chavan S; Parekh H; Chitnis M
    Neoplasma; 1992; 39(1):49-57. PubMed ID: 1528304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential macrophage-mediated cytotoxicity to P388 leukemia cells and its drug-resistant cells examined by a new MTT assay.
    Jiao H; Soejima Y; Ohe Y; Miura K; Tamura T; Saijo N
    Leuk Res; 1992 Dec; 16(12):1175-80. PubMed ID: 1465025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrotriazole AK-2123 enhances mitomycin C activity in mice bearing multidrug-resistant tumors.
    Goncharova SA; Rajewskaya TA; Konovalova NP; Kagiya TV
    J Chemother; 2001 Dec; 13(6):635-40. PubMed ID: 11806625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A; Cohen L; Glaubiger D
    Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.